US Broker Ratings

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Potential 169% Upside Amid Strong Buy Ratings

Investors looking for promising opportunities in the biotechnology sector may want to keep a close eye on Viking Therapeutics, Inc. (NASDAQ: VKTX). The San Diego-based company, with a market capitalization..

Xenon Pharmaceuticals Inc. (XENE): Analyst Consensus Highlights 26.65% Potential Upside

Xenon Pharmaceuticals Inc. (XENE), a trailblazer in the biotechnology landscape focused on neurological and psychiatric disorders, is drawing significant attention in the healthcare sector. With a market cap of $6.21..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring an 83.24% Potential Upside in Biotech

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a promising player in the biotechnology sector, is capturing the attention of investors with its potential upside of 83.24%. Headquartered in Naarden, the Netherlands,..

LifeStance Health Group (LFST) Investor Outlook: Analyzing Growth Potential Amid Strong Revenue Growth and Analyst Confidence

LifeStance Health Group, Inc. (NASDAQ: LFST), a healthcare company specializing in outpatient mental health services, has captured investor attention with its robust revenue growth and positive analyst ratings. With a..

Warby Parker Inc. (WRBY) Stock Analysis: Exploring the 15% Upside Potential and Analyst Confidence

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector, specializing in medical instruments and supplies, has carved a niche for itself in the eyewear industry. With a..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Exploring an 18% Potential Upside with Strong Revenue Growth

Harmony Biosciences Holdings, Inc. (HRMY) stands as a compelling player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $2.27 billion, this U.S.-based company has..

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Analysis: A Biotech Gem with 24.74% Upside

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a prominent player in the biotechnology sector, is capturing significant investor attention with its promising pipeline and robust market potential. With a market capitalization of..

Alvotech (ALVO) Stock Analysis: Potential Upside and Strategic Positioning in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based biosimilar manufacturer, is carving out a notable niche in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring the Biotech’s Unprecedented 3,749% Revenue Growth

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) has carved a niche in the biotechnology sector with its innovative approach to treating complex medical conditions. With a staggering 3,749.20% revenue growth, this healthcare..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: High ROE and Revenue Growth Highlight Investment Potential

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), a key player in the global biopharmaceutical landscape, is attracting investor attention with its robust 613.02% return on equity (ROE) and a noteworthy 9.90% revenue..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: High Revenue Growth Amidst Clinical Advancements

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) has recently captured the attention of investors within the healthcare sector, particularly in biotechnology, due to its staggering 2,336.30% revenue growth. This milestone, however, is..

ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: Promising Pipeline and Potential Upside

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, is capturing investor interest with its robust pipeline and promising revenue growth metrics. As a leading biopharmaceutical company..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: A 31% Potential Upside in the Biotechnology Sector

For investors with a keen interest in the biotechnology sector, PTC Therapeutics, Inc. (NASDAQ: PTCT) presents a compelling opportunity with a significant potential upside. With a market capitalization of $6.23..

Sotera Health Company (SHC) Stock Analysis: Key Insights on Its 19.78% Potential Upside

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector, not only for its robust market cap of $5.41 billion but also for its promising growth potential. As a..

Ultragenyx Pharmaceutical Inc. (RARE) Investor Outlook: Nearly 100% Upside Potential According to Analyst Ratings

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands out in the biotechnology sector with its distinctive focus on rare and ultra-rare genetic diseases. The company’s innovative approach and robust product pipeline have..

Perrigo Company plc (PRGO) Stock Analysis: Evaluating the 30.54% Upside Potential

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, offers a wide range of over-the-counter health and wellness solutions across the Americas and international markets. With its..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Assessing Growth Potential with a 57.94% Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands as a significant player in the biotechnology sector, a space known for its innovative strides in healthcare solutions. With a market capitalization of $9.4..

Elanco Animal Health (ELAN) Investor Outlook: Assessing a 41% Potential Upside Amid Strong Buy Ratings

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is making waves with its promising growth potential...

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A Strong Buy with 12% Upside Potential

Merit Medical Systems, Inc. (MMSI), a prominent player in the healthcare sector, is capturing investor attention with its robust growth trajectory and promising analyst ratings. Specializing in the design and..

Prestige Consumer Healthcare (PBH): Analyst Ratings and Growth Potential Offer 23% Upside for Investors

Prestige Consumer Healthcare Inc. (PBH), a key player in the healthcare sector, operates in the specialty and generic drug manufacturing industry. Headquartered in Tarrytown, New York, this company has a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds